We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$115B
AUM Growth
+$6.24B
Cap. Flow
+$1B
Cap. Flow %
0.87%
Top 10 Hldgs %
23.71%
Holding
4,165
New
247
Increased
1,898
Reduced
1,581
Closed
296

Sector Composition

Rank Sector Weight
1 Technology 14.47%
2 Healthcare 8.69%
3 Financials 8.53%
4 Industrials 6.69%
5 Consumer Discretionary 5.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRNS icon
2851
Transcat
TRNS
$888M
$557K ﹤0.01%
6,236
+1,039
+20% +$88.4K
SIMO icon
2852
Silicon Motion
SIMO
$8.45B
$557K ﹤0.01%
8,507
+1,071
+14% +$70.3K
QCRH icon
2853
QCR Holdings
QCRH
$1.73B
$557K ﹤0.01%
12,675
MHI
2854
DELISTED
Pioneer Municipal High Income Fund
MHI
$556K ﹤0.01%
62,583
+2,299
+4% +$20.5K
HUSV icon
2855
First Trust Horizon Managed Volatility Domestic ETF
HUSV
$84.9M
$556K ﹤0.01%
17,224
-40,219
-70% -$1.3M
ECC
2856
Eagle Point Credit Company
ECC
$505M
$555K ﹤0.01%
49,655
+4,309
+10% +$46.7K
B
2857
CALL
Barrick Mining
B
$67.3B
$554K ﹤0.01%
34,600
-98,400
-74% -$1.77M
KMT icon
2858
Kennametal
KMT
$2.35B
$552K ﹤0.01%
20,015
+194
+1% +$5.35K
INSM icon
2859
Insmed
INSM
$28.9B
$551K ﹤0.01%
32,333
+4,542
+16% +$88.2K
CIM
2860
Chimera Investment
CIM
$993M
$551K ﹤0.01%
32,566
+1,350
+4% +$25.8K
ALKS icon
2861
Alkermes
ALKS
$8.44B
$550K ﹤0.01%
19,528
-354
-2% -$9.64K
NMFC icon
2862
New Mountain Finance
NMFC
$728M
$550K ﹤0.01%
45,226
-8,793
-16% -$111K
PMT
2863
PennyMac Mortgage Investment
PMT
$827M
$550K ﹤0.01%
44,620
+14,177
+47% +$191K
NUSC icon
2864
Nuveen ESG Small-Cap ETF
NUSC
$1.35B
$548K ﹤0.01%
15,481
-980
-6% -$35.7K
BRKL
2865
DELISTED
Brookline Bancorp
BRKL
$548K ﹤0.01%
52,190
+316
+0.6% +$3.98K
ATRA icon
2866
Atara Biotherapeutics
ATRA
$83.1M
$548K ﹤0.01%
7,556
+287
+4% +$27.8K
GBDC icon
2867
Golub Capital BDC
GBDC
$3.48B
$547K ﹤0.01%
40,321
+698
+2% +$9.41K
LBRDA icon
2868
Liberty Broadband Class A
LBRDA
$5.07B
$546K ﹤0.01%
6,649
-3,639
-35% -$314K
PROF
2869
Profound Medical
PROF
$252M
$545K ﹤0.01%
58,661
-34,691
-37% -$401K
BCLI
2870
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$544K ﹤0.01%
10,980
-3,200
-23% -$92.8K
VRNT
2871
DELISTED
Verint Systems
VRNT
$543K ﹤0.01%
14,588
+2,987
+26% +$111K
TNK icon
2872
Teekay Tankers
TNK
$2.81B
$542K ﹤0.01%
12,631
-3,936
-24% -$146K
TBBK icon
2873
The Bancorp
TBBK
$2.83B
$540K ﹤0.01%
19,389
+21
+0.1% +$667
PKX icon
2874
POSCO
PKX
$17.3B
$540K ﹤0.01%
7,744
+287
+4% +$17.7K
CASH icon
2875
Pathward Financial
CASH
$1.78B
$539K ﹤0.01%
12,992
-2,996
-19% -$141K

Similar funds

Raymond James & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, Raymond James & Associates held 4,165 positions worth $115B, up 5.7% from $109B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q1 2023 filing shows 247 new, 1,898 increased, 1,581 reduced and 296 closed positions. Its largest new stake was VanEck Morningstar International Moat ETF: 787,215 shares worth $25.2M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $551M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q1 2023 buy was VanEck Morningstar International Moat ETF: 787,215 shares worth $25.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q1 2023, an estimated $413M increase.
  • Raymond James & Associates's biggest Q1 2023 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $551M.
  • Raymond James & Associates fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $18.8M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $115B portfolio in Q1 2023.
  • Raymond James & Associates opened 247 new positions and closed 296 in Q1 2023.
  • Raymond James & Associates's portfolio value rose 5.7% quarter-over-quarter to $115B.

Based on Raymond James & Associates's 13F filing for Q1 2023, filed 14 Apr 2023.